YOLFTbeta
00

Guizhou Xinbang Pharmaceutical Co Ltd

002390 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

2.93CNY-0.04 (-1.35%)

Price History

Full chart

Market Stats

Previous Close2.97
Open2.96
Day Range2.92 – 2.97
52-Week Range2.51 – 4.03
Volume17.41M
Market Cap5.75B
P/E (TTM)49.33
Forward P/E0.00
EPS0.06
Dividend Yield3.04%
Beta0.12
50-Day Avg3.02
200-Day Avg3.14

About

Guizhou Xinbang Pharmaceutical Co., Ltd. manufactures and sells traditional Chinese medicine and other pharmaceutical products in China and internationally. The company cardiovascular and cerebrovascular, digestive system, endocrine, tumors and immunomodulatory drugs, blood system drugs, rheumatism and rheumatoid arthritis, urinary system, antipyretic and analgesic, cold medicine, gynecological, and anti-infective drugs and medications. It also provides medical services. The company was founded in 1995 and is headquartered in Guiyang, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMs. Lingzhong Kong
  • Employees4.70K
  • HeadquartersKekai No.1 Courtyard, Guiyang, China, 550018, China
  • Websitehttps://www.xinbang.com

Leadership

  • Ms. Lingzhong KongGM & Director · b. 1968
  • Ms. Yajun Xiao CPACFO & Deputy GM · b. 1973
  • Ms. Yafang LuDeputy General Manager · b. 1969
  • Ms. Chuan ChenDeputy GM & Secretary of the Board · b. 1969
  • Mr. Zhangjie QingDeputy General Manager · b. 1975
  • Mr. Chi LuoDeputy General Manager · b. 1990
  • Juan LiaoAccounting Supervisor & Head of Accounting Department

Financials

Income Statement

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Revenue173.33M217.75M274.74M336.69M318.63M361.87M447.57M569.49M2.48B4.18B5.16B6.00B6.58B6.66B5.85B6.47B6.35B6.46B6.03B
Growth (%)-+25.63%+26.17%+22.55%-5.36%+13.57%+23.68%+27.24%+334.81%+68.80%+23.38%+16.39%+9.63%+1.14%-12.16%+10.71%-1.88%+1.75%-6.63%
Cost of Revenue60.74M76.64M85.39M103.40M111.23M128.71M166.98M213.94M1.84B3.32B4.05B4.75B5.15B5.19B4.59B5.12B5.13B5.24B5.00B
Gross Profit112.59M137.59M189.35M233.28M207.40M233.16M280.59M355.55M638.33M861.13M1.11B1.26B1.43B1.46B1.25B1.35B1.22B1.22B1.03B
Gross Margin64.96%63.19%68.92%69.29%65.09%64.43%62.69%62.43%25.78%20.60%21.49%20.93%21.79%22.01%21.41%20.90%19.16%18.90%17.11%
Operating Expense91.43M109.51M156.44M180.03M168.48M184.56M234.88M318.06M463.28M676.72M880.71M834.19M2.63B1.12B964.17M900.99M900.64M836.02M777.06M
Operating Income21.16M28.07M32.92M53.25M38.92M48.59M45.71M37.49M175.05M184.41M227.48M422.42M-1.20B345.00M287.40M451.51M316.32M385.03M254.85M
Operating Margin12.21%12.89%11.98%15.82%12.21%13.43%10.21%6.58%7.07%4.41%4.41%7.04%-18.17%5.18%4.92%6.98%4.98%5.96%4.22%
EBITDA26.84M44.52M46.24M61.80M55.04M67.78M53.26M66.47M284.59M418.21M471.42M664.80M662.00M714.47M635.29M767.42M567.89M619.72M491.06M
EBITDA Margin15.48%20.44%16.83%18.36%17.28%18.73%11.90%11.67%11.49%10.01%9.14%11.08%10.06%10.74%10.87%11.86%8.94%9.59%8.14%
Net Income17.45M29.91M33.61M46.69M37.76M46.08M47.83M40.24M144.77M174.38M246.01M319.38M-1.30B236.30M173.52M272.87M224.37M287.23M101.38M
Net Income Margin10.07%13.74%12.23%13.87%11.85%12.73%10.69%7.07%5.85%4.17%4.77%5.32%-19.70%3.55%2.97%4.22%3.53%4.45%1.68%
R&D-----2.79M6.03M7.30M5.01M6.94M25.39M30.17M36.69M36.58M10.56M1.94M1.21M4.67M9.73M
R&D as % of Total Revenue-----0.77%1.35%1.28%0.20%0.17%0.49%0.50%0.56%0.55%0.18%0.03%0.02%0.07%0.16%
Interest Expense4.27M9.20M9.43M6.46M3.47M7.45M11.78M16.58M75.09M126.22M132.14M107.60M152.48M166.21M100.41M101.17M52.52M40.48M24.44M
Interest Expense % of Total Revenue2.47%4.23%3.43%1.92%1.09%2.06%2.63%2.91%3.03%3.02%2.56%1.79%2.32%2.50%1.72%1.56%0.83%0.63%0.41%

Balance Sheet

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Assets379.34M391.07M442.73M470.35M1.13B1.24B1.33B1.49B5.22B6.50B10.80B11.95B10.85B10.42B9.66B9.63B9.79B9.24B9.03B
Total Liabilities235.18M216.99M235.04M217.51M165.81M264.02M311.99M450.69M2.77B3.84B4.31B5.20B5.69B5.37B4.49B2.80B2.73B2.10B2.01B
Total Equity142.80M172.65M206.49M253.18M960.22M980.26M1.02B1.03B2.40B2.54B6.35B6.62B4.97B4.84B4.92B6.62B6.81B6.85B6.71B
Cash62.42M39.85M71.12M83.36M629.20M513.31M360.12M254.40M659.04M603.12M1.67B2.15B1.61B1.24B1.78B624.65M899.18M805.98M1.02B
Total Debt201.95M177.95M195.95M173.95M134.86M194.86M235.11M321.86M1.81B2.36B2.79B3.69B4.20B3.76B3.38B1.39B1.37B817.41M773.34M
Net Debt139.53M138.10M124.83M90.59M-494.34M-318.45M-125.01M67.46M1.15B1.75B1.12B1.54B2.59B2.52B1.61B762.46M468.60M11.43M-242.18M

Cash Flow

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Operating Cash Flow7.35M32.49M24.86M41.75M2.50M-39.87M-36.46M-21.34M-198.60M217.40M-198.59M201.74M-218.56M886.33M742.11M457.97M590.80M790.62M634.97M
Investing Cash Flow-42.41M-22.33M-1.97M-3.16M-78.62M-102.53M-128.09M-136.90M-373.12M-451.87M-600.27M-440.16M-216.29M-253.32M408.00M-744.34M-118.02M50.26M-115.03M
Financing Cash Flow41.00M-32.72M8.36M-26.36M621.96M26.51M11.36M52.52M927.09M171.72M1.82B682.97M-96.97M-982.77M-587.16M-910.57M-189.42M-908.18M-317.91M
Capital Expenditure39.27M28.95M6.97M6.65M74.62M96.48M52.76M44.80M282.64M492.48M432.23M435.03M263.52M207.54M138.09M253.76M158.78M135.78M124.87M
Free Cash Flow-31.92M3.54M17.89M35.11M-72.12M-136.35M-89.23M-66.14M-481.23M-275.08M-630.82M-233.29M-482.08M678.79M604.02M204.21M432.02M654.84M510.10M
Dividends Paid11.00M8.72M9.64M6.36M3.47M33.49M21.39M26.25M89.12M154.73M179.60M185.88M252.54M206.95M197.56M230.34M168.36M116.63M192.29M
FCF to OCF-434.54%10.89%71.96%84.08%-2883.49%342.00%244.70%309.96%242.32%-126.53%317.66%-115.64%220.57%76.58%81.39%44.59%73.12%82.83%80.33%
Dividend Paid to FCF-34.47%246.48%53.89%18.12%-4.82%-24.56%-23.97%-39.69%-18.52%-56.25%-28.47%-79.68%-52.39%30.49%32.71%112.80%38.97%17.81%37.70%

Earnings

Report DateJun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014Apr 27, 2014Aug 26, 2014Oct 24, 2014Feb 27, 2015Apr 23, 2015Jul 29, 2015Oct 30, 2015Feb 26, 2016Apr 25, 2016Aug 18, 2016Oct 24, 2016Feb 27, 2017Apr 5, 2017Aug 28, 2017Oct 25, 2017Feb 27, 2018Apr 20, 2018Aug 27, 2018Oct 26, 2018Dec 31, 2018Apr 29, 2019Aug 27, 2019Oct 25, 2019Apr 30, 2020Aug 27, 2020Oct 27, 2020Mar 29, 2021Apr 29, 2021Aug 25, 2021Oct 28, 2021Mar 14, 2022Apr 29, 2022Aug 24, 2022Oct 28, 2022Apr 28, 2023Aug 28, 2023Oct 29, 2023Apr 28, 2024Aug 31, 2024Oct 30, 2024Apr 29, 2025Aug 30, 2025Oct 29, 2025Apr 30, 2026Aug 28, 2026
EPS Estimate---------------0.030.030.030.040.040.040.050.070.070.080.100.150.150.100.060.060.060.060.06--------------------------
EPS Actual0.030.010.010.010.020.010.020.010.020.010.020.010.010.010.020.010.040.040.060.030.030.040.030.030.050.040.030.030.050.060.040.040.070.04-0.940.040.040.050.020.030.060.030.050.050.030.030.040.030.06-0.010.050.050.020.030.03-0.040.030.020.030.03
Surprise----------------82.33%33.33%33.33%50.00%-25.00%-25.00%-20.00%-57.14%-57.14%-37.50%-60.00%-80.00%-80.00%-50.00%0.00%-33.33%-33.33%16.67%-33.33%--------------------------
Timing---------------After-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-Pre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-market-Pre-marketPre-market----

Key Statistics & Ratios

Market Cap5.75B
Enterprise Value4.77B
Trailing P/E49.33
Forward P/E0.00
PEG Ratio0.00
Price / Sales1.10
Price / Book0.85
EPS0.06
Book Value3.56
Revenue (TTM)5.24B
Gross Profit (TTM)887.73M
EBITDA460.31M
Profit Margin2.15%
Operating Margin5.47%
Return on Equity2.66%
Return on Assets1.98%
Shares Outstanding1.94B
Shares Float1.00B
Beta0.12
Dividend Yield3.04%
Dividend Rate0.09
Payout Ratio117.80%

Dividends

20261×
0.06May 21, 2026
20252×
0.03Sep 26, 20250.03May 21, 2025
20242×
0.03Oct 29, 20240.06May 17, 2024
20231×
0.06May 30, 2023
20221×
0.06May 24, 2022
20181×
0.03Jun 22, 2018
20171×
0.03Jun 23, 2017
20161×
0.03Jun 6, 2016
20151×
0.02May 25, 2015
20141×
0.01Jun 16, 2014
20131×
0.01Jun 25, 2013
20121×
0.01Jun 11, 2012
20111×
0.03May 5, 2011

Stock Splits

  • May 25, 201525:10
  • Jun 16, 201420:10
  • May 5, 201120:10